The Rs 250 crore group has appointed international
consultancy firm Ernst & Young to design the company's
expansion plans and advise on a fund-raising programme.
Muhammed Majeed, chairman & managing
director, said, “Till recently, we were an Indian
multinational company with the US as our focus market and
limited presence in India. We are now looking at consolidating
our group companies under one umbrella and expand our operations
in India in a big way. We envisage an investment of around
Rs 100-200 crore over an one-year period.”
Besides Sami Labs, the other group companies
include Sabinsa Corporation (in the US), Organic Aromatics
and Anju Phytochemicals. The company has offices spread
across Japan, China, Dubai, Europe apart from the US. The
group's product portfolio includes nutraceuticals, standardised
herbal extracts, fine chemicals, cosmeceuticals, probiotics
and various enzymes.
The company is also planning to foray into
formulations. It also has plans to set up a formulations
manufacturing unit in India.
It has invested close to Rs 60 crore in
its existing four production units at Bangalore, Singasandra,
Kunigal and Mysore. It also invested Rs 6 crore in its research
& development unit based in Bangalore.